EUVIMEDEUVIMED entdecken
Crossref

Lymphovenous Bypass for Immediate Lymphatic Reconstruction in Breast Cancer Patients Undergoing Axillary Lymph Node Dissection: Minimizing the Risk of Upper Extremity Lymphedema

Maria C Médor, Isabella F Churchill, Diego Pereira, Amanda Roberts, Erin Cordeiro, Lisa Findlay-Shirras, Jing Zhang, Moein Momtazi

Journal of Reconstructive Microsurgery · 01.11.2024 · 40 (09) · 713-721

DOI: 10.1055/s-0044-1785680 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Reconstructive Microsurgery, erschienen am 01.11.2024. Verfasst von Maria C Médor und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division of Plastic Surgery, University of Montreal, Montreal, Quebec, Canada. Hauptthemen laut MEDLINE: Breast Neoplasms, Lymph Node Excision, Quality of Life, Lymphatic Vessels. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 42 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Studies have shown a significant reduction in breast cancer-related lymphedema (BCRL) rates in patients undergoing complete axillary lymph node dissection (cALND) combined with immediate lymphatic reconstruction (ILR) using lymphovenous bypass (LVB).The purpose of this study was to determine if ILR with LVB at the time of cALND results in a decreased incidence of BCRL and its impact on patient quality of life (QOL).

Methods

In this prospective cohort study, patients ≥ 18 years requiring cALND underwent ILR from 2019 to 2021. The primary outcome was bilateral upper limb volumes measured by Brørson's truncated cone formula and the Pero-System (3D Körper Scanner). The secondary outcome was QOL measured by the Lymphedema Quality of Life (LYMQOL) arm patient-reported outcome measurement.

Results

Forty-two patients consented to ILR using LVB. ILR was completed in 41 patients with a mean of 1.9 ± 0.9 lymphovenous anastomosis performed. Mean age of patients was 52.4 ± 10.5 years with a mean body mass index of 27.5 ± 4.9 kg/m2. All patients (n = 39, 100%) received adjuvant therapy after ILR. Mean follow-up was 15.2 ± 5.1 months. Five patients met criteria for lymphedema throughout the duration of the study (12.8%), with two patients having resolution, with an overall incidence of 7.7% by the end of the study period. Patients with lymphedema were found to have statistically significant lower total LYMQOL values at 18 months (8.44 ± 1.17 vs. 3.23 ± 0.56, p < 0.001). A mean increase of 0.73 ± 3.5 points was observed for overall QOL average for upper limb function at 18 months compared with 3 months (t = 0.823, p = 0.425).

Conclusion

This study showed an incidence of 7.7% lymphedema development throughout the duration of study. We also showed that ILR has the potential to reduce the significant long-term adverse outcomes of lymphedema and improve QOL for patients undergoing cALND

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsLymph Node ExcisionQuality of LifeLymphatic VesselsAxillaBreast Cancer LymphedemaHumansFemaleMiddle AgedProspective StudiesAdultUpper ExtremityAnastomosis, SurgicalLymphedemaPostoperative ComplicationsPlastic Surgery Procedures

Autor:innen und Institutionen

  • Division of Plastic Surgery, University of Montreal, Montreal, Quebec, Canada.
  • Division of Plastic Surgery, McMaster University, Hamilton, Ontario, Canada.
  • Division of Plastic Surgery, The Ottawa Hospital, Ottawa, Ontario, Canada.
  • Division of General Surgery, The Ottawa Hospital, Ottawa, Ontario, Canada.
  • Division of Plastic Surgery, University of Alberta, Edmonton, Alberta, Canada.

Zitieren

APA

Médor, M. C., Churchill, I. F., Pereira, D., Roberts, A., Cordeiro, E., Findlay-Shirras, L., Zhang, J., & Momtazi, M. (2024). Lymphovenous Bypass for Immediate Lymphatic Reconstruction in Breast Cancer Patients Undergoing Axillary Lymph Node Dissection: Minimizing the Risk of Upper Extremity Lymphedema. Journal of Reconstructive Microsurgery, 40(09), 713-721. https://doi.org/10.1055/s-0044-1785680

Vancouver

Médor MC, Churchill IF, Pereira D, Roberts A, Cordeiro E, Findlay-Shirras L, et al. Lymphovenous Bypass for Immediate Lymphatic Reconstruction in Breast Cancer Patients Undergoing Axillary Lymph Node Dissection: Minimizing the Risk of Upper Extremity Lymphedema. Journal of Reconstructive Microsurgery. 2024;40(09):713-721. doi:10.1055/s-0044-1785680

BibTeX
@article{Mdor2024,
  author = {Médor, Maria C and Churchill, Isabella F and Pereira, Diego and Roberts, Amanda and Cordeiro, Erin and Findlay-Shirras, Lisa and Zhang, Jing and Momtazi, Moein},
  title = {Lymphovenous Bypass for Immediate Lymphatic Reconstruction in Breast Cancer Patients Undergoing Axillary Lymph Node Dissection: Minimizing the Risk of Upper Extremity Lymphedema},
  journal = {Journal of Reconstructive Microsurgery},
  year = {2024},
  volume = {40},
  number = {09},
  pages = {713--721},
  doi = {10.1055/s-0044-1785680}
}
Kostenlos starten →